Division of Clinical Data Analytics and Decision Support University of Arizona College of Medicine-Phoenix AZ.
Department of Pharmacy Practice and Science University of Arizona College of Pharmacy Phoenix AZ.
J Am Heart Assoc. 2022 Jun 7;11(11):e024338. doi: 10.1161/JAHA.122.024338. Epub 2022 Jun 3.
Background Torsade de pointes (TdP) is a potentially fatal cardiac arrhythmia that is often drug induced. Clinical decision support (CDS) may help minimize TdP risk by guiding decision making in patients at risk. CDS has been shown to decrease prescribing of high-risk medications in patients at risk of TdP, but alerts are often ignored. Other risk-management options can potentially be incorporated in TdP risk CDS. Our goal was to evaluate actions clinicians take in response to a CDS advisory that uses a modified Tisdale QT risk score and presents management options that are easily selected (eg, single click). Methods and Results We implemented an inpatient TdP risk advisory systemwide across a large health care system comprising 30 hospitals. This CDS was programmed to appear when prescribers attempted ordering medications with a known risk of TdP in a patient with a QT risk score ≥12. The CDS displayed patient-specific information and offered relevant management options including canceling offending medications and ordering electrolyte replacement protocols or ECGs. We retrospectively studied the actions clinicians took within the advisory and separated by drug class. During an 8-month period, 7794 TdP risk advisories were issued. Antibiotics were the most frequent trigger of the advisory (n=2578, 33.1%). At least 1 action was taken within the advisory window for 2700 (34.6%) of the advisories. The most frequent action taken was ordering an ECG (n=1584, 20.3%). Incoming medication orders were canceled in 793 (10.2%) of the advisories. The frequency of each action taken varied by drug class (<0.05 for all actions). Conclusions A modified Tisdale QT risk score-based CDS that offered relevant single-click management options yielded a high action/response rate. Actions taken by clinicians varied depending on the class of the medication that evoked the TdP risk advisory, but the most frequent was ordering an ECG.
尖端扭转型室性心动过速(TdP)是一种潜在致命的心律失常,通常由药物引起。临床决策支持(CDS)可以通过指导有 TdP 风险的患者做出决策,帮助最小化 TdP 风险。CDS 已被证明可以减少 TdP 风险患者中高危药物的处方,但警报经常被忽视。其他风险管理选项可以潜在地纳入 TdP 风险 CDS。我们的目标是评估临床医生在响应使用改良 Tisdale QT 风险评分的 CDS 咨询时所采取的行动,并提出易于选择的管理选项(例如,单次点击)。
我们在一个由 30 家医院组成的大型医疗保健系统中实施了一种全系统的 TdP 风险咨询系统。当处方者在 QT 风险评分≥12 的患者中尝试开具有 TdP 已知风险的药物时,该 CDS 会出现。CDS 显示患者特定信息,并提供相关的管理选项,包括取消引起的药物和订购电解质替代方案或心电图。我们回顾性研究了在咨询中临床医生采取的行动,并按药物类别进行了分类。在 8 个月期间,发出了 7794 次 TdP 风险咨询。抗生素是最常见的咨询触发因素(n=2578,33.1%)。在咨询窗口内至少采取了 1 项行动的有 2700 次(34.6%)。最常见的行动是订购心电图(n=1584,20.3%)。在 793 次咨询(10.2%)中取消了新入药物医嘱。采取的每种行动的频率因药物类别而异(所有行动均<0.05)。
基于改良 Tisdale QT 风险评分的 CDS,提供相关的单次点击管理选项,产生了较高的行动/响应率。临床医生采取的行动取决于引发 TdP 风险咨询的药物类别,但最常见的是订购心电图。